InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: None

Wednesday, 05/27/2015 3:01:43 PM

Wednesday, May 27, 2015 3:01:43 PM

Post# of 6723
Tekmira Pharmaceuticals Corp Analyst Rating Update

May 27, 2015

Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) has received a short term rating of buy from research analysts at Zacks with a rank of 2. The company has been rated an average of 1 by 4 Wall Street Analysts. 4 analysts have added the counter in their list of strong buys.

Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) shares are expected to touch $30 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 3.67. The target price could hit $35 on the higher end and $26 on the lower end.

http://thedailyrover.com/tekmira-pharmaceuticals-corp-analyst-rating-update/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News